Prolonged Remission and Good Quality of Life with Maintenance Chemotherapy in Recurrent Ewing’s Sarcoma
XD01-XD03
Correspondence
Dr. Wesley Mannirathil Jose,
Associate Professor, Department of Medical Oncology and Haematology, Cancer Institute, Amrita Institute of Medical Sciences,
Amrita Vishwa Vidyapeetham, Amrita University, Kochi-682041, Kerala, India.
E-mail: wesleymjose@aims.amrita.edu
Ewing’s sarcoma is an aggressive tumour of bone commonly affecting individuals in 10-20 years of age group. Older age and metastatic disease has an overall poor outcome. We are reporting a case of a 37-year-old lady with Ewing’s sarcoma who was initially diagnosed with localised disease involving C5-7 vertebral bodies. She received conventional treatment. She relapsed three years later with metastatic disease and was treated with salvage treatment followed by high dose chemotherapy and autologous stem cell transplant. She had a second relapse with lung metastasis after 28 months. She was treated with gemcitabine and docetaxel and she achieved complete remission again. She is on maintenance chemotherapy with cyclophosphamide and etoposide and continues to be in remission on maintenance treatment.